Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Much ado about nothing: Methicillin-resistant Staphylococcus aureus
T. Shannon
, P. Edgar
, C. Villarreal
, D. N. Herndon
,
L. G. Phillips
, John P. Heggers
Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Much ado about nothing: Methicillin-resistant Staphylococcus aureus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Methicillin-resistant Staphylococcus Aureus
100%
Much Ado About Nothing
100%
Mortality Rate
50%
Gram-negative
50%
Morbidity Mortality
33%
Hospital Stay
16%
Intensive Care Unit
16%
Escherichia Coli
16%
Therapeutic Agents
16%
Pseudomonas Aeruginosa (P. aeruginosa)
16%
Morbidity Rate
16%
Antimicrobial Therapy
16%
Mortality Costs
16%
Antimicrobial
16%
Gram-positive
16%
Staphylococcus Aureus
16%
Staphylococcus Epidermidis (S. epidermidis)
16%
Treatment Costs
16%
Documented Infection
16%
Antibiotic Costs
16%
Cost Factors
16%
Gram-negative Isolates
16%
Gram-negative Infections
16%
Wound Isolate
16%
Rate Factor
16%
Medicine and Dentistry
Methicillin Resistant Staphylococcus Aureus
100%
Health Care Cost
83%
Methicillin-Resistant Staphylococcus Epidermidis
66%
Mortality Rate
50%
Infection
33%
Wound
16%
Antiinfective Agent
16%
Intensive Care Unit
16%
Pseudomonas aeruginosa
16%
Staphylococcus Aureus
16%
Antimicrobial Therapy
16%
Escherichia coli
16%
Staphylococcus Epidermidis
16%
Gram-Negative Bacterial Infection
16%
Pharmacology, Toxicology and Pharmaceutical Science
Methicillin-Resistant Staphylococcus Aureus
100%
Methicillin-Resistant Staphylococcus Epidermidis
66%
Mortality Rate
50%
Infection
33%
Wound
16%
Pseudomonas aeruginosa
16%
Antiinfective Agent
16%
Escherichia coli
16%
Staphylococcus Aureus
16%
Antimicrobial Therapy
16%
Staphylococcus Epidermidis
16%
Gram Negative Infection
16%
Immunology and Microbiology
Methicillin-Resistant Staphylococcus Aureus
100%
Methicillin-Resistant Staphylococcus Epidermidis
66%
Mortality Rate
50%
Infection
50%
Pseudomonas aeruginosa
16%
Escherichia coli
16%
Staphylococcus Aureus
16%
Staphylococcus Epidermidis
16%
Biochemistry, Genetics and Molecular Biology
Methicillin Resistant Staphylococcus Aureus
100%
Methicillin-Resistant Staphylococcus Epidermidis
66%
Mortality Rate
50%
Escherichia coli
16%
Pseudomonas aeruginosa
16%
Staphylococcus Aureus
16%
Staphylococcus Epidermidis
16%